After 17 years of despair, I’d been on 14 completely different antidepressant remedy combos and years of personal speak remedy. None of those therapies actually had any results and my situation continued to worsen.
Mark, Lived Expertise Knowledgeable
Melancholy is without doubt one of the main causes of sick well being worldwide. In 2019, depressive problems had been among the many ten greatest causes of years misplaced to sick well being and early demise for each younger folks and working-age adults (Vos et al, 2020). For a 3rd of individuals, their despair can be “tough to deal with” and they’re going to proceed to expertise important burden regardless of making an attempt first line therapies resembling antidepressant drugs and group speaking therapies (Al-Harbi, 2012).
Now we have just lately held a webinar on the background and proof on a remedy for difficult-to-treat despair known as “transcranial magnetic stimulation” (TMS). TMS was really helpful by NICE to be used throughout the NHS in 2015 (NICE, 2015) though it’s only out there in 1 in 7 psychological well being trusts at current (it’s extra extensively out there privately).
The webinar lined:
- The invention of TMS (trace: it’s a British invention!)
- Proof on medical and value effectiveness
- New approaches to enhance entry and availability of remedy
- Experiences of transcranial magnetic stimulation from three folks with lived expertise of despair.
Right here I cowl a few of the proof on medical effectiveness and security of TMS in addition to ongoing analysis to enhance response charges and remedy accessibility. Hyperlinks to numerous helpful assets are on the backside, as is a hyperlink to a survey we’re operating to get some suggestions on perceptions of TMS from potential referrers (main care and psychological well being clinicians) that we are going to use to information our work on new TMS remedy pathways.
What’s TMS?
TMS is a kind of “neuromodulation” (non-invasive mind stimulation) remedy for despair. It makes use of magnetic pulses to re-balance exercise, and improve flexibility (plasticity), inside and throughout mind networks (Downar et al, 2024). Sufferers come for a number of remedy classes per clinic go to over a couple of weeks for a complete of about thirty therapies. At every session, a remedy coil is positioned on their head (often over an space known as the left pre-frontal cortex). Every remedy is just round ten minutes of stimulation utilizing the most recent pulse sequences. The magnetic pulses trigger temporary present move inside focused mind areas. A affected person has TMS while they’re awake and alert. It’s completely different to “electroconvulsive remedy” (ECT) and doesn’t contain an anaesthetic or affect reminiscence.
The medical effectiveness of TMS
When NICE really helpful TMS for despair in 2015, it primarily based this on 4 systematic critiques exhibiting its medical efficacy. The most important introduced collectively findings from 32 randomised managed trials (trials that examine lively TMS to inactive/sham/placebo TMS) (Lepping et al, 2014).
A 2019 evaluate introduced collectively 63 randomised managed trials in folks with a present episode of despair (Mutz et al, 2019). A 2025 evaluate targeted on 16 trials in folks with treatment-resistant despair, that means despair that hasn’t responded to 2 or extra antidepressants (Saelens et al, 2025). Each discovered actual remedy labored higher than sham for the 2 forms of stimulation most utilized in clinics: customary high-frequency stimulation and intermittent theta burst stimulation (Desk 1). Within the 2025 evaluate, theta burst stimulation ranked first out of 25 therapies for remission, forward of electroconvulsive remedy.
Two extra targeted critiques reported danger ratios, that are simpler to interpret (Vida et al, 2023; Kishi et al, 2024). They counsel actual remedy roughly doubles the prospect of response and remission in contrast with sham.
| Assessment | Commonplace high-frequency stimulation | Intermittent theta burst stimulation |
|---|---|---|
| Mutz et al, 2019 Adults with a present episode of despair (unipolar or bipolar) |
Response: OR 3.17 (2.29 to 4.37) Remission: OR 2.67 (1.79 to 4.00) |
Response: OR 3.20 (1.45 to 7.08) Remission: OR 3.30 (1.38 to 7.90) Not important as soon as excessive danger of bias trials had been eliminated |
| Saelens et al, 2025 Remedy-resistant unipolar despair |
Response: OR 4.01 (2.36 to six.81) | Response: OR 4.80 (2.21 to 10.39) Ranked first of 25 therapies for remission |
| Vida et al, 2023 Melancholy after two failed antidepressants |
Response: RR 2.25 (1.71 to 2.97) Remission: RR 2.78 (1.40 to five.53) |
Not studied |
| Kishi et al, 2024 Adults with despair |
Not studied | Response: RR 2.00 (1.28 to three.13) Remission: RR 2.16 (1.01 to 4.62) |
A 2018 trial that in contrast the 2 forms of stimulation instantly discovered theta burst was no much less efficient than customary stimulation (Blumberger et al, 2018), though some folks could do higher with one than the opposite. The large benefit of theta burst is pace: a session takes 3 to 10 minutes, in contrast with 20 to 40 minutes for normal stimulation.
A big UK multi-centre trial of individuals with average to extreme difficult-to-treat despair (with a median period of despair of 6 to 7 years) discovered that those that benefited might count on to remain nicely out to no less than six months post-treatment (Morriss et al, 2024). (Some sufferers will keep nicely past this, while others may want a top-up course of TMS, or different therapies resembling drugs, to remain nicely). That trial delivered twenty remedy classes per affected person. Some sufferers responded rapidly, however others confirmed a delayed response, suggesting longer remedy programs could also be helpful (Briley et al, 2024). Certainly, a retrospective case collection discovered a dose-response relationship with variety of remedy classes, out to thirty classes and past (Hutton et al, 2023).
Importantly, since folks with difficult-to-treat despair usually have multi-factorial difficulties, transcranial magnetic stimulation may be readily mixed with different therapies, together with drugs and speaking therapies. A big US trial in contrast three subsequent steps for folks whose antidepressant hadn’t labored: including transcranial magnetic stimulation, including an antipsychotic, or switching antidepressant (Papakostas et al, 2024). Including transcranial magnetic stimulation improved despair scores greater than switching (Desk 2). In one other trial, when given alongside cognitive behavioural remedy, transcranial magnetic stimulation was more practical than switching antidepressant (Dalhuisen et al, 2024).
| Subsequent step after an antidepressant hasn’t labored | Responded | Recovered (remission) |
|---|---|---|
| Add transcranial magnetic stimulation | 52% | 34% |
| Add an antipsychotic (aripiprazole) | 38% | 25% |
| Change antidepressant | 36% | 25% |
I responded late into remedy, however they prolonged the remedy from the 20 to the 30 classes. And amazingly, I made a full restoration… I went from struggling to learn just some paragraphs to being in educational research.
Mark, Lived Expertise Knowledgeable
The security of TMS
TMS was invented on the College of Sheffield within the mid-Nineteen Eighties and so shouldn’t be a brand new remedy. Its first makes use of had been for neurological evaluation. American psychiatrists noticed the potential for treating despair and ran the primary giant multi-centre randomised managed trial twenty years in the past.
As a result of TMS makes use of magnetic fields, some folks can not have TMS and a few precautions ought to be adopted (Trapp et al, 2025). There are comparable precautions to MRI mind scans, though the magnetic area with TMS is far more focal than for MRI. Due to this fact, specific considerations are conductive steel or electronics close to the remedy coil. TMS makes a loud click on when it delivers a magnetic pulse, so sufferers and clinicians ought to put on ear plugs throughout a remedy session.
The 2 most severe unwanted side effects are syncope (fainting) and seizure. Nevertheless, these are uncommon. Syncope is mostly early in a remedy course and in individuals who have beforehand skilled this for different causes (e.g., throughout blood exams). In folks with out epilepsy, the danger of a seizure is round 1 in 30,000 per session (1 in 1,400 throughout an entire remedy course) (Taylor et al, 2021). TMS workers are skilled to handle seizures and syncope and have protocols in place. In folks with epilepsy, seizure danger has been estimated at 2 to three% throughout a remedy course, which must be factored into any concerns of dangers and advantages (Stultz et al, 2020).
Extra generally, folks have gentle unwanted side effects throughout or shortly after remedy, primarily scalp ache or discomfort and headache. A 2022 evaluate of 53 sham-controlled trials discovered these had been the one unwanted side effects extra widespread with actual remedy than with sham (Wang et al, 2022). Desk 3 exhibits how usually either side impact occurs and what helps.
| Facet impact | How widespread | What helps |
|---|---|---|
| Scalp ache on the remedy website | 24% with actual remedy, 5% with sham | Often settles over classes; small adjustments to coil place or depth |
| Headache | 23% with actual remedy, 16% with sham | Regular over-the-counter painkillers |
| Scalp discomfort | 11% with actual remedy, 5% with sham | As for scalp ache |
| Loud click on with every pulse | Each session | Ear plugs for sufferers and workers |
| Fainting | Uncommon; principally early in a course, in individuals who have fainted earlier than | Employees skilled, with protocols in place |
| Seizure (folks with out epilepsy) | About 1 in 30,000 classes, or 1 in 1,400 folks over a course | Employees skilled, with protocols in place |
| Seizure (folks with epilepsy) | About 2 to three% over a course | Dangers and advantages weighed up earlier than remedy |
Future instructions for TMS
Not everybody advantages from TMS. There are a number of how being explored to assist extra sufferers receive extra profit extra rapidly (Peng et al, 2026). As already famous, larger profit can usually be achieved by delivering extra remedy classes. “Accelerated” approaches, which ship a number of remedy classes per day, can enable a remedy course to be delivered in a shorter timeframe (van Rooij et al, 2024).
Priming approaches might be able to increase response or doubtlessly cut back the variety of remedy classes required. This contains TMS priming, during which a special (usually shorter) TMS pulse sequence is given in the beginning of every session to extend the responsivity of the mind to the principle remedy (this was probably the most efficient neuromodulation approaches within the 2019 evaluate by Mutz et al).
Alternatively, one other sort of well-tolerated neuromodulation, transcranial direct present stimulation (tDCS), which makes use of weak electrical currents (robust sufficient to mild up a small LED), might be able to prime TMS (Shickle et al, 2026). Priming approaches modify processes underlying mind plasticity, such that the mind turns into extra aware of the results of TMS (“meta-plasticity”). There may be current proof {that a} remedy that quickly modulates mind plasticity (D-cycloserine) will help to compress a TMS remedy course into one or two days (Vaughn et al, 2025).
In addition to lowering the variety of remedy classes that sufferers require, approaches to extend remedy flexibility are wanted. One such method might be a weekly remedy protocol, during which sufferers attend for a number of classes as soon as every week, maybe supported by psychotherapeutic actions (or digital therapeutics) which have been studied together with TMS (Dalhuisen et al, 2024), to enhance or delay efficacy. It could be potential to ship a weekly remedy in a cellular clinic that visits completely different GP practices or well being hubs on completely different days, reaching folks of their communities. We’re presently exploring the potential of this method.
It is going to be vital to make sure that new developments improve, fairly than worsen, entry for underserved teams. Our current survey discovered that consciousness of neuromodulation therapies is low, and that there are socio-demographic variations in perceptions of security and efficacy (Tan et al, 2026). Respondents recognized a number of potential limitations to entry, but additionally methods to deal with these that ought to be integrated into remedy companies and future trials.
I’m one of many fortunate ones that has been supplied it and being out there to me in my area. So luck shouldn’t come into it.
Matt, Lived Expertise Knowledgeable
Discover out extra about TMS
Melancholy is without doubt one of the most disabling situations confronted by folks within the UK, and we want to have the ability to provide the total vary of efficient therapies. TMS is a secure and clinically and cost-effective remedy (Cox et al, 2026) and ought to be extra extensively out there on the NHS.
A hyperlink to our web site which incorporates the webinar and assets on the proof and security of TMS is at: https://mindtech.org.uk/analysis/research-themes/our-projects/tms-transcranial-magnetic-stimulation
Our web site a couple of new venture on approaches to reinforce response to TMS and enhance remedy accessibility (EnhanceTMS) is at: https://mindtech.org.uk/analysis/research-themes/our-projects/etms
The price effectiveness of TMS can be lined in a future weblog.
Major care and psychological well being clinicians are invited to take our five-minute survey: we wish to perceive perceptions of TMS amongst clinicians who may refer sufferers for remedy sooner or later. It will information our work creating new TMS remedy pathways. You’ll be able to win a present voucher and obtain a certificates evidencing your engagement on this exercise: https://app.onlinesurveys.jisc.ac.uk/s/nottingham/tms-survey-clinicians
Watch our TMS movies and webinar
Assertion of curiosity
Paul Briley is a Consulting Neuroscience Specialist for The Science Behind, a division of Brainbox Ltd. He’s an writer of a number of research cited on this weblog (Briley et al, 2024; Morriss et al, 2024; Peng et al, 2026; Shickle et al, 2026; Tan et al, 2026) and is concerned within the EnhanceTMS venture.
Edited by
André Tomlin.
Proof for TMS: a brief bibliography
Abdelnaim MA, Langguth B, Deppe M. et al (2020) Anti-suicidal efficacy of repetitive transcranial magnetic stimulation in depressive sufferers: a retrospective evaluation of a giant pattern. Frontiers in Psychiatry 2020 10 929. https://doi.org/10.3389/fpsyt.2019.00929
Al-Harbi KS (2012) Remedy-resistant despair: therapeutic traits, challenges, and future instructions. Affected person Choice and Adherence 2012 6 369-388. https://doi.org/10.2147/PPA.S29716
Blumberger DM, Vila-Rodriguez F, Thorpe KE. et al (2018) Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in sufferers with despair (THREE-D): a randomised non-inferiority trial. The Lancet 2018 391(10131) 1683-1692. https://doi.org/10.1016/S0140-6736(18)30295-2
Briley PM, Webster L, Lankappa S. et al (2024) Trajectories of enchancment with repetitive transcranial magnetic stimulation for treatment-resistant main despair within the BRIGhTMIND trial. npj Psychological Well being Analysis 2024 3(1) 32. https://doi.org/10.1038/s44184-024-00077-8
Cox E, Ma J, Roadevin C. et al (2026) Is it time for psychological well being companies to spend money on neurostimulation? An financial analysis of transcranial magnetic stimulation therapies for the remedy of average to extreme treatment-resistant despair within the UK. BMJ Psychological Well being 2026 29(1) e302237. https://doi.org/10.1136/bmjment-2025-302237
Dalhuisen I, van Oostrom I, Spijker J. et al (2024) rTMS as a subsequent step in antidepressant nonresponders: a randomized comparability with present antidepressant remedy approaches. American Journal of Psychiatry 2024 181(9) 806-814. https://doi.org/10.1176/appi.ajp.20230556
Downar J, Siddiqi SH, Mitra A. et al (2024) Mechanisms of motion of TMS within the remedy of despair. Present Subjects in Behavioral Neurosciences 2024 66 233-277. https://doi.org/10.1007/7854_2024_483
Hutton TM, Aaronson ST, Carpenter LL. et al (2023) Dosing transcranial magnetic stimulation in main depressive dysfunction: relations between variety of remedy classes and effectiveness in a big affected person registry. Mind Stimulation 2023 16(5) 1510-1521. https://doi.org/10.1016/j.brs.2023.10.001
Kishi T, Ikuta T, Sakuma Ok. et al (2024) Repetitive transcranial magnetic stimulation for bipolar despair: a scientific evaluate and pairwise and community meta-analysis. Molecular Psychiatry 2024 29(1) 39-42. https://doi.org/10.1038/s41380-023-02045-8
Kishi T, Ikuta T, Sakuma Ok. et al (2024) Theta burst stimulation for despair: a scientific evaluate and community and pairwise meta-analysis. Molecular Psychiatry 2024 29(12) 3893-3899. https://doi.org/10.1038/s41380-024-02630-5
Lepping P, Schönfeldt-Lecuona C, Sambhi RS. et al (2014) A scientific evaluate of the medical relevance of repetitive transcranial magnetic stimulation. Acta Psychiatrica Scandinavica 2014 130(5) 326-341. https://doi.org/10.1111/acps.12276
Morriss R, Briley PM, Webster L. et al (2024) Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for treatment-resistant despair: a randomized managed trial. Nature Drugs 2024 30(2) 403-413. https://doi.org/10.1038/s41591-023-02764-z
Mutz J, Vipulananthan V, Carter B. et al (2019) Comparative efficacy and acceptability of non-surgical mind stimulation for the acute remedy of main depressive dysfunction in adults: systematic evaluate and community meta-analysis. BMJ 2019 364 l1079. https://doi.org/10.1136/bmj.l1079
NICE (2015) Repetitive transcranial magnetic stimulation for despair. HealthTech steering [HTG396]. London: Nationwide Institute for Well being and Care Excellence.
Papakostas GI, Trivedi MH, Shelton RC. et al (2024) Comparative effectiveness analysis trial for antidepressant incomplete and non-responders with remedy resistant despair (ASCERTAIN-TRD): a randomized medical trial. Molecular Psychiatry 2024 29(8) 2287-2295. https://doi.org/10.1038/s41380-024-02468-x
Peng Y, Webster L, Lankappa S. et al (2026) Augmentation methods for transcranial magnetic stimulation (TMS) within the remedy of unipolar despair: a scoping evaluate. Journal of Affective Problems Experiences 2026 25 101058. https://doi.org/10.1016/j.jadr.2026.101058
Saelens J, Gramser A, Watzal V. et al (2025) Relative effectiveness of antidepressant therapies in treatment-resistant despair: a scientific evaluate and community meta-analysis of randomized managed trials. Neuropsychopharmacology 2025 50(6) 913-919. https://doi.org/10.1038/s41386-024-02044-5
Shickle J, Axford A, Tan SF. et al (2026) Combining transcranial electrical and magnetic stimulation: a scoping evaluate of neurophysiological and medical research. Medical Neurophysiology 2026 2112437. https://doi.org/10.1016/j.clinph.2026.2112437
Stultz DJ, Osburn S, Burns T. et al (2020) Transcranial magnetic stimulation (TMS) security with respect to seizures: a literature evaluate. Neuropsychiatric Illness and Remedy 2020 16 2989-3000. https://doi.org/10.2147/NDT.S276635
Tan SF, Shickle J, Webster L. et al (2026) Potential acceptability and limitations to uptake for non-invasive mind stimulation for psychological well being remedy: a co-produced nationwide survey of individuals with lived expertise of psychological well being situations. Analysis Sq. 2026 (preprint). https://doi.org/10.21203/rs.3.rs-9814760/v1
Taylor JJ, Newberger NG, Stern AP. et al (2021) Seizure danger with repetitive TMS: survey outcomes from over a half-million remedy classes. Mind Stimulation 2021 14(4) 965-973. https://doi.org/10.1016/j.brs.2021.05.012
Trapp NT, Purgianto A, Taylor JJ. et al (2025) Consensus evaluate and concerns on TMS to deal with despair: a complete replace endorsed by the Nationwide Community of Melancholy Facilities, the Medical TMS Society, and the Worldwide Federation of Medical Neurophysiology. Medical Neurophysiology 2025 170 206-233. https://doi.org/10.1016/j.clinph.2024.12.015
van Rooij SJH, Arulpragasam AR, McDonald WM. et al (2024) Accelerated TMS: transferring rapidly into the way forward for despair remedy. Neuropsychopharmacology 2024 49(1) 128-137. https://doi.org/10.1038/s41386-023-01599-z
Vaughn DA, Marino B, Engelbertson A. et al (2025) Actual-world effectiveness of a single-day routine for transcranial magnetic stimulation utilizing Optimized, Neuroplasticity-Enhanced strategies in Melancholy (ONE-D): an open-label case collection. Transcranial Magnetic Stimulation 2025 5 100200. https://doi.org/10.1016/j.transm.2025.100200
Vida RG, Sághy E, Bella R. et al (2023) Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive remedy for main depressive dysfunction (MDD) after two antidepressant remedy failures: meta-analysis of randomized sham-controlled trials. BMC Psychiatry 2023 23(1) 545. https://doi.org/10.1186/s12888-023-05033-y
Vos T, Lim SS, Abbafati C. et al (2020) World burden of 369 illnesses and accidents in 204 nations and territories, 1990-2019: a scientific evaluation for the World Burden of Illness Research 2019. The Lancet 2020 396(10258) 1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9
Wang W-L, Wang S-Y, Hung H-Y. et al (2022) Security of transcranial magnetic stimulation in unipolar despair: a scientific evaluate and meta-analysis of randomized-controlled trials. Journal of Affective Problems 2022 301 400-425. https://doi.org/10.1016/j.jad.2022.01.047
